This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lowe, P.
Right arrow Articles by Vohra, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lowe, P.
Right arrow Articles by Vohra, R.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, July 2006, p. 2619-2621, Vol. 44, No. 7
0095-1137/06/$08.00+0     doi:10.1128/JCM.00476-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Comparison of the Gen-Probe APTIMA Combo 2 Assay to the AMPLICOR CT/NG Assay for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine Samples from Australian Men and Women

Peter Lowe,* Peter O'Loughlin, Kathryn Evans, Michael White, Paul B. Bartley, and Renu Vohra

QML Pathology, Brisbane, Australia

Received 6 March 2006/ Returned for modification 21 April 2006/ Accepted 2 May 2006

The performance of the APTIMA Combo 2 assay (AC2) for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in urine samples was compared to that of the AMPLICOR CT/NG assay (AMP). The AC2 performance was superior to that of AMP for both organisms in this study.

* Corresponding author. Mailing address: Infectious Diseases and Immunology, QML Pathology, 60 Ferry Road, West End 4101, Brisbane, Australia. Phone: (07) 3840 4510. Fax: (07) 3840 4014. E-mail: peter.lowe{at}qml.com.au.

Journal of Clinical Microbiology, July 2006, p. 2619-2621, Vol. 44, No. 7
0095-1137/06/$08.00+0     doi:10.1128/JCM.00476-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Pittrof, R, Hitchings, S, FitzGerald, M, Pittrof, R, Hitchings, S, FitzGerald, M (2009). Questioning the value of screening for gonorrhoea in symptomless heterosexual men. Int J STD AIDS 20: 741-744 [Abstract] [Full Text]  
  • Ho, M K, Lo, J Y C, Lo, A C T, Cheng, F K, Chan, F K (2009). Evaluation of replacing the existing diagnostic strategy for Neisseria gonorrhoeae and Chlamydia trachomatis infections with sole molecular testing of urine specimens in a sexually transmitted infection clinic setting. Sex. Transm. Infect. 85: 322-325 [Abstract] [Full Text]  
  • Munson, E., Boyd, V., Czarnecka, J., Griep, J., Lund, B., Schaal, N., Hryciuk, J. E. (2007). Evaluation of Gen-Probe APTIMA-Based Neisseria gonorrhoeae and Chlamydia trachomatis Confirmatory Testing in a Metropolitan Setting of High Disease Prevalence. J. Clin. Microbiol. 45: 2793-2797 [Abstract] [Full Text]  
  • Lum, G., Garland, S. M., Tabrizi, S., Harnett, G., Smith, D. W., Sloots, T. P., Whiley, D. M., Tapsall, J. W., Lowe, P., O'Loughlin, P., Bartley, P. B., Vohra, R., Evans, K., White, M. (2006). Supplemental Testing Is Still Required in Australia for Samples Positive for Neisseria gonorrhoeae by Nucleic Acid Detection Tests.. J. Clin. Microbiol. 44: 4292-4294 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»